Everolimus as second-line therapy for metastatic renal cell carcinoma: a 'real-life' study.
about
Clinical experience with everolimus in the second-line treatment of advanced renal cell carcinomaPazopanib in Metastatic Renal Cancer: A "Real-World" Experience at National Cancer Institute "Fondazione G. Pascale"Axitinib after Sunitinib in Metastatic Renal Cancer: Preliminary Results from Italian "Real-World" SAX Study.Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma.Clinical management of metastatic kidney cancer: the role of new molecular drugs.Everolimus treatment in advanced solid tumors: a personal view
P2860
Everolimus as second-line therapy for metastatic renal cell carcinoma: a 'real-life' study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Everolimus as second-line ther ...... arcinoma: a 'real-life' study.
@en
Everolimus as second-line ther ...... arcinoma: a 'real-life' study.
@nl
type
label
Everolimus as second-line ther ...... arcinoma: a 'real-life' study.
@en
Everolimus as second-line ther ...... arcinoma: a 'real-life' study.
@nl
prefLabel
Everolimus as second-line ther ...... arcinoma: a 'real-life' study.
@en
Everolimus as second-line ther ...... arcinoma: a 'real-life' study.
@nl
P2093
P2860
P356
P1433
P1476
Everolimus as second-line ther ...... carcinoma: a 'real-life' study
@en
P2093
Antonio Febbraro
Beniamino Casale
Clementina Savastano
Giuseppe Di Lorenzo
Giuseppe Grimaldi
Luigi De Lucia
Luigi Maiorino
Mimma Rizzo
Roberta Formato
P2860
P304
P356
10.2217/FON.14.170
P407
P577
2014-07-31T00:00:00Z